Public procurement notice: Contract Notice
Published: 2016-05-14
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) (‘the Authority’)
Country: UK
Region: SCOTLAND
Contract type: Supplies
Procedure: Open procedure
CPV classification: 33600000: Pharmaceutical products | 33612000 | 33630000: Medicinal products for dermatology | 33631000 | 33632100
Estimated value: 27000000 GBP
Submission deadline: 2016-06-15
Award criteria: The most economic tender

Technical requirements: The supply of Infliximab 100mg powder for concentrate for solution for infusion to Health Boards across NHS Scotland.
All NHS Scotland Health Boards, Special Health Boards and the Authority or other NHS organisation established pursuant to the NHS (Scotland) Act 1978.
The Supply of Infliximab 100mg powder for concentrate for solution for infusion to Health Boards across NHS Scotland.
The Authority is entitled at its sole discretion to extend by up to a further two (2) period of twelve (12) months each by giving a minimum of 3 months written notice of such extension.
In addition to II.2.3) The main site and place of performance also includes Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.
Economic operators may be excluded from this competition if they are in any of the situations referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015.
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current MHRA/EMEA (European Agency) market authorisation, or equivalent, for all Goods tendered.
(b) Potential Framework Participants must have an efficient and robust Quality Management System in place that allows management of all systems under the Framework Agreement and ensures that procedures from manufacturing of the Goods through to delivery and payment are carried out in an efficient and responsible manner and also includes post delivery processes such as for management of medicine recalls/drug alerts issued by the Medicine and Healthcare Products Regulatory Agency (‘MHRA’) and Medicines Information enquiries from Participating Authorities.
(c) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
NHS National Services Scotland, National Procurement, Canderside, 2 Swinhill Avenue, Larkhall, ML9 2QX.
The estimated value range referred to Sections II.1.5) and II.2.6) covers the twelve (12) months initial duration and the full twenty four (24) month extension option.
Note: The buyer is using PCS-Tender to carry out this procurement process. Please note this is a separate website and if you are not already registered, registration will be required.
To access PCS-Tender, record your interest in this notice and access the tender documentation please visit https://www.publictendersscotland.publiccontractsscotland.gov.uk and search for project Code project_5940 under ITTs Open to All Suppliers. Please use the Search/Filter function, then select Project Code from the drop-down. Please note that once you have expressed interest in the ITT it will move to your My ITTs area.
For further information on using PCS-Tender, please read the Supplier Response Guide: https://www.publictendersscotland.publiccontractsscotland.gov.uk/esop/pts-host/public/pts/supplierhelppage/PCS-TSupplierResponseGuide.pdf
If you have already registered on Public Contracts Scotland and PCS-Tender and paired your accounts you can access PCS-Tender through your Public Contracts Scotland Control Panel.


Award value: 27000000